Guillain-Barré syndrome associated with COVID-19: a case report study

被引：0
作者：
Javad Hosseini Nejad
Mohammad Heiat
Mohammad Javad Hosseini
Fakhri Allahyari
Ali Lashkari
Raheleh Torabi
Reza Ranjbar
机构：
[1] Neuroscience Research Center,Baqiyatallah Research Center for Gastroenterology and Liver Diseases
[2] Baqiyatallah University of Medical Sciences,Molecular Biology Research Center, Systems Biology and Poisonings Institute
[3] Baqiyatallah University of Medical Sciences,Institute of Biochemistry and Biophysics (IBB)
[4] Baqiyatallah University of Medical Sciences,Laboratory of Bioanalysis, Institute of Biochemistry & Biophysics
[5] University of Tehran,undefined
[6] Tehran University,undefined
来源：
Journal of NeuroVirology | 2021年 / 27卷
关键词：
Acute respiratory distress syndrome; COVID-19; Guillain-Barré syndrome;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Acute respiratory distress syndrome (ARDS) caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is spreading around the world. Patients with coronavirus disease 2019 (COVID-19) typically present fever, cough, and respiratory illnesses. It has been revealed that the comorbidities can turn it into severe types, and the managements meet unpredicted complications. Here, we report a case of coronavirus disease 2019 (COVID-19) coincidence with confirmed acute Guillain-Barré syndrome (GBS). Ten days after admission and therapeutic process, the patient developed autonomic dysfunction. Despite respiratory support and receiving intravenous immunoglobulin, the patient died due to cardiac arrest. Albeit it is yet scientifically doubtful, there are raising concerns toward a possible association between GBS and SARS-CoV-2 infection, demonstrating potential neurological symptoms of COVID-19.
引用
收藏
页码：802 / 805
页数：3
相关论文
共 54 条
[1]  
Arnaud S(2020)Post SARS-CoV-2 Guillain-Barré syndrome Clin Neurophysiol 131 1652-1654
[2]  
Budowski C(2020)Neurological complications of coronavirus and COVID-19 Rev Neurol 70 311-322
[3]  
Ng Wing Tin S(2020)Emerging coronaviruses: first SARS, second MERS and third SARS-CoV-2: epidemiological updates of COVID-19 Infez Med 28 6-17
[4]  
Degos B(2017)Neurological complications during treatment of Middle East respiratory syndrome J Clin Neurol (Seoul, Korea) 13 227-233
[5]  
Carod-Artal FJ(2020)COVID-19 and the eye immunity: lesson learned from the past and possible new therapeutic insights Int Ophthalmol 40 1057-1060
[6]  
Halaji M(2020)Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports Neurol Sci 41 3149-3156
[7]  
Farahani A(2001)Diagnostic and classification criteria for the Guillain-Barré syndrome Eur Neurol 45 133-139
[8]  
Ranjbar R(2020)Guillain-Barré syndrome associated with SARS-CoV-2 infection IDCases 20 e00771-727
[9]  
Heiat M(2016)Guillain-Barré syndrome Lancet 388 717-2304
[10]  
Dehkordi FS(2012)Guillain-Barré syndrome N Engl J Med 366 2294-384
123456